Kourosh Davarpanah, Inato CEO

Big Phar­ma-part­nered clin­i­cal tri­al match­mak­er se­cures $20M to im­prove plat­form

A com­pa­ny with pub­lic links to Sanofi and Mod­er­na has raised more mon­ey to ex­pand its mis­sion of im­prov­ing di­ver­si­ty and en­roll­ment in clin­i­cal tri­als.

Ina­to put the word out on Wednes­day that it raised $20 mil­lion via an A2 round to ad­vance its match­ing plat­form be­tween phar­ma com­pa­nies and po­ten­tial clin­i­cal tri­al sites.

Ina­to CEO Kourosh Davarpanah told End­points News that with the $20 mil­lion in hand, it will pur­sue im­prove­ments to its di­ver­si­ty of­fer­ings, its fo­cus on on­col­o­gy and da­ta col­lec­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.